Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | ATM | Q13315 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | ESRRG | P62508 | 6/20 | 0.52 |
| ▸ | RAB9A | P51151 | 7/20 | 0.44 |
| ▸ | NPC1 | O15118 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ESRRB | O95718 | 2/20 | 0.43 |
| ▸ | GALR3 | O60755 | 1/20 | 0.42 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tebufenpyrad SCHEMBL8407688 | 0.87 | LMNA (0.59) | LMNAMAPTATML3MBTL1RAB9A | |
| Tebufenpyrad SCHEMBL26848 | 0.87 | LMNA (0.59) | LMNAMAPTATML3MBTL1RAB9A | |
| SCHEMBL15220624 | 0.81 | LMNA (0.54) | LMNAMAPTATML3MBTL1ESRRG | |
| SCHEMBL11938496 | 0.81 | LMNA (0.72) | LMNAMAPTATML3MBTL1RAB9A | |
| SCHEMBL10061335 | 0.80 | LMNA (0.57) | LMNAMAPTATML3MBTL1RAB9A | |
| SCHEMBL14188833 | 0.79 | LMNA (0.56) | LMNAMAPTATML3MBTL1RAB9A | |
| SCHEMBL20968014 | 0.77 | LMNA (0.59) | LMNAMAPTATML3MBTL1RAB9A | |
| SCHEMBL11938500 | 0.77 | LMNA (0.59) | LMNAMAPTATML3MBTL1RAB9A | |
| SCHEMBL13557817 | 0.77 | LMNA (0.59) | LMNAMAPTATML3MBTL1RAB9A | |
| SCHEMBL14262522 | 0.77 | LMNA (0.54) | LMNAMAPTATML3MBTL1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160044922-A1 | Control of Ectoparasites | BAYER ANIMAL HEALTH GMBH | 2016-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160044922-A1 | Control of Ectoparasites | TYR, EPX, PIGO | LMNA 3808/4885MAPT 3079/4885ATM 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.